Your search returned 19 results.

Sort
Results
1.
Toward a Better Understanding of the Differential Impact of Heart Failure Phenotypes After Breast Cancer. MedStar authors:
  • Barac, Ana
PMID:
  • 35687827
Year: 2022
Citation:
  • Journal of Clinical Oncology. 40(32):3688-3691, 2022 Nov 10.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barac A, Cheng RK, Hovsepyan G, Reding KW, Simon MS, Stefanick M, Vasbinder A
2.
Quo Vadis Trastuzumab?: Navigating Cardiac Safety Risk Estimates With Complex Cancer Treatments. MedStar authors:
  • Barac, Ana
PMID:
  • 30819378
Year: 2019
Citation:
  • JACC Heart Failure. 7(3):225-227, 2019 03.
Institution:
  • MedStar Heart & Vascular Institutena
Medline publication type:
  • Comment
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Barac A
3.
Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy: End of One Size Fits All. MedStar authors:
  • Barac, Ana
PMID:
  • 31171093
Year: 2019
Citation:
  • Journal of the American College of Cardiology. 73(22):2869-2871, 2019 06 11.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Barac A, Blaes A, Lynce F
4.
Cardiovascular Disease After Aromatase Inhibitor Use. MedStar authors:
  • Barac, Ana
PMID:
  • 27100398
Year: 2016
Citation:
  • JAMA Oncology. 2(12):1590-1597, 2016 Dec 01
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Amundsen B, Avila C, Barac A, Chlebowski RT, Chung J, Haque R, Schottinger JE, Shi J, Xu X
5.
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial. MedStar authors:
  • Barac, Ana
PMID:
  • 32031879
Year: 2020
Citation:
  • Journal of Clinical Oncology. 38(13):1419-1428, 2020 05 01.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Anderson GL, Aragaki AK, Barac A, Chlebowski RT, Johnson KC, Lane DS, Luo J, Manson JE, Mossavar-Rahmani Y, Neuhouser ML, Pan K, Prentice RL, Rohan TE, Snetselaar L, Thomson CA, Wactawski-Wende J, Women's Health Initiative
6.
Good News, Bad News, but Not Fake News. MedStar authors:
  • Barac, Ana
PMID:
  • 28396377
Year: 2017
Citation:
  • Circulation. 135(15):1413-1416, 2017 Apr 11
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Editorial
Form of publication:
  • Journal Article
All authors:
  • Barac A, Plana JC
7.
Cardiac Protection in HER2-Targeted Treatment: How Should We Measure New Strategies?. MedStar authors:
  • Barac, Ana
  • Swain, Sandra M
PMID:
  • 27356170
Year: 2016
Citation:
  • JAMA Oncology. 2(8):1037-9, 2016 Aug 01
Institution:
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barac A, Swain SM
8.
Racial and ethnic disparities in treatment-related heart disease mortality among US breast cancer survivors. MedStar authors:
  • Barac, Ana
PMID:
  • 36943362
Year: 2023
Citation:
  • JNCI Cancer Spectrum. 7(2), 2023 03 01.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Intramural
Form of publication:
  • Journal Article
All authors:
  • Barac A, Berrington de Gonzalez A, Ho KL, Lawrence WR, Ramin C, Rhee J, Veiga LHS, Vo JB
9.
Low-Fat Dietary Modification and Risk of Ductal Carcinoma In Situ of the Breast in the Women's Health Initiative Dietary Modification Trial. MedStar authors:
  • Barac, Ana
PMID:
  • 34187856
Year: 2021
Citation:
  • Cancer Epidemiology, Biomarkers & Prevention. 30(9):1753-1756, 2021 09.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Barac A, Chlebowski R, Crane TE, Lane DS, Manson JE, Pan K, Peila R, Rohan TE, Saquib N, Shadyab AH, Tabung FK, Wassertheil-Smoller S, Zhang Z
10.
Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors. MedStar authors:
  • Barac, Ana
PMID:
  • 30659431
Year: 2019
Citation:
  • Breast Cancer Research & Treatment. 174(3):785-794, 2019 Apr.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barac A, Chlebowski RT, Haque R, Shi J, Xu X
11.
Trends in heart disease mortality among breast cancer survivors in the US, 1975-2017. MedStar authors:
  • Barac, Ana
PMID:
  • 35107712
Year: 2022
Citation:
  • Breast Cancer Research & Treatment. 192(3):611-622, 2022 Apr.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barac A, Berrington de Gonzalez A, Ramin C, Veiga L, Vo JB
12.
Trastuzumab-Induced Cardiomyopathy. [Review] MedStar authors:
  • Barac, Ana
  • Gates, Emily
PMID:
  • 31587782
Year: 2019
Citation:
  • Cardiology Clinics. 37(4):407-418, 2019 Nov.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Barac A, Barish R, Gates E
13.
Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative. MedStar authors:
  • Barac, Ana
PMID:
  • 33151547
Year: 2021
Citation:
  • Cancer. 127(4):598-608, 2021 02 15.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Banack HR, Barac A, Beebe-Dimmer JL, Caan BJ, Chlebowski RT, Foraker R, Hastert TA, Hovsepyan G, Liu S, Luo J, Manson JE, Neuhouser ML, Okwuosa TM, Pan K, Qi L, Ruterbusch JJ, Shadyab AH, Simon MS, Thomson CA, Wactawski-Wende J, Waheed N
14.
Breast Cancer and Heart Failure. [Review] MedStar authors:
  • Barac, Ana
PMID:
  • 30449381
Year: 2019
Citation:
  • Heart Failure Clinics. 15(1):65-75, 2019 Jan.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Almuwaqqat Z, Barac A, Meisel JL, Parashar S
15.
The Role of Angiotensin-Converting Enzyme Inhibitors and beta-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients. [Review] MedStar authors:
  • Barac, Ana
PMID:
  • 31960742
Year: 2020
Citation:
  • Journal of the American Heart Association. 9(2):e015327, 2020 01 21.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barac A, Brown SA, Okwuosa TM, Volgman AS
16.
Cardiovascular risk and communication among early stage breast cancer survivors. MedStar authors:
  • Barac, Ana
PMID:
  • 28215826
Year: 2017
Citation:
  • Patient Education & Counseling. 100(7):1360-1366, 2017 Jul.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Barac A, Christian AH, Hudson SV, Miller SM, O'Malley D
17.
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 28314836
Year: 2017
Citation:
  • Oncologist. 22(5):518-525, 2017 May
Institution:
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
18.
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Herbolsheimer, Pia M
  • Lynce, Filipa
  • Mete, Mihriye
  • Nunes, Raquel
  • Shara, Nawar M
  • Swain, Sandra M
  • Wray, Lynette
PMID:
  • 26749359
Year: 2016
Citation:
  • Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
  • MedStar Health Research Institute
  • MedStar Health Research Institute
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
  • Washington Cancer Institute
  • Washington Cancer Institute A
  • Washington Cancer Instituteia
Department:
  • MedStar Heart Institute
  • MedStar Heart Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
19.
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Cunningham, A
  • Gallagher, Christopher
  • Hofmeyer, Mark
  • Srichai, M B
  • Swain, Sandra M
PMID:
  • 30852761
Year: 2019
Citation:
  • Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun.
Institution:
  • MedStar Health
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Department:
  • Associate Dean for Research Development
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF
Pages

Powered by Koha